T20/DP178 is an activator of human phagocyte formyl peptide receptors
US6830893B2 · kind B2 · utility
1Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2001 |
| Grant date | Dec 14, 2004 |
| Priority date | — |
| Expiry date | Dec 8, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16122
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the discovery that T20/DP178, T21/DP107, and fragments thereof interact with members of the formyl peptide receptor family and thereby modulate cell migration and activation. Novel biological tools, prophylactics, therapeutics and methods of use of the foregoing for modulating an inflammatory response are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.